2022
DOI: 10.1016/j.slast.2022.06.003
|View full text |Cite
|
Sign up to set email alerts
|

Buildout and integration of an automated high-throughput CLIA laboratory for SARS-CoV-2 testing on a large urban campus

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(11 citation statements)
references
References 23 publications
0
11
0
Order By: Relevance
“…Our LOD is lower than that reported for SalivaDirect (6-12 SARS-CoV-2 copies per µL) 28 , which has a similar sample work ow, but relies on the less sensitive RT-qPCR platform 41 . Most other screening assays report LODs within this range as well (0.5-10.6 copies per µl) 16,17,18,19,20,21,22 . For pooled samples our LOD was 12 copies per µl, which is in line with at least one other report 20 and considered an acceptable trade-off for screening assays in which frequency and turnaround time rather than sensitivity are more important for mitigation of viral spread 42 .…”
Section: Discussionmentioning
confidence: 88%
See 1 more Smart Citation
“…Our LOD is lower than that reported for SalivaDirect (6-12 SARS-CoV-2 copies per µL) 28 , which has a similar sample work ow, but relies on the less sensitive RT-qPCR platform 41 . Most other screening assays report LODs within this range as well (0.5-10.6 copies per µl) 16,17,18,19,20,21,22 . For pooled samples our LOD was 12 copies per µl, which is in line with at least one other report 20 and considered an acceptable trade-off for screening assays in which frequency and turnaround time rather than sensitivity are more important for mitigation of viral spread 42 .…”
Section: Discussionmentioning
confidence: 88%
“…To facilitate efforts to return to in-person learning, routine screening was proposed to identify infected, asymptomatic individuals and, in combination with other interventions, mitigate the spread of SARS-CoV-2 6 . Many universities developed or implemented screening assays, using a variety of sample types (saliva vs nasal swabs), sample processing (minimal vs RNA extraction), e ciency strategies (pooled vs unpooled), and platforms (qPCR, RT-LAMP, antigen tests), although the majority relied on qPCR 7,8,9,10,11,12,13,14,15,16,17,18,19,20,21,22 . A recent analysis of 1,400 institutions of higher education (IHE) showed that the success of these screening efforts extended to their housed counties, as those with IHEs that conducted widespread testing had fewer hospitalizations and deaths 23 .…”
Section: Introductionmentioning
confidence: 99%
“…Our LOD is lower than that reported for SalivaDirect (6-12 SARS-CoV-2 copies per µL) 24 , which has a similar sample work ow, but relies on the less sensitive RT-qPCR platform 37 . Most other screening assays report LODs within this range as well (0.5-10.6 copies per µl) 12,13,14,15,16,17,18 . For pooled samples our LOD was 12 copies per µl, which is in line with at least one other report 16 and considered an acceptable trade-off for screening assays in which frequency and turnaround time rather than sensitivity are more important for mitigation of viral spread 38 .…”
Section: Discussionmentioning
confidence: 89%
“…To facilitate efforts to return to in-person learning, routine screening was proposed to identify infected, asymptomatic individuals and, in combination with other interventions, mitigate the spread of SARS-CoV-2 2 . Many universities developed or implemented screening assays, using a variety of sample types (saliva vs nasal swabs), sample processing (minimal vs RNA extraction), e ciency strategies (pooled vs unpooled), and platforms (qPCR, RT-LAMP, antigen tests), although the majority relied on qPCR 3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18 . A recent analysis of 1,400 institutions of higher education (IHE) showed that the success of these screening efforts extended to their housed counties, as those with IHEs that conducted widespread testing had fewer hospitalizations and deaths 19 .…”
Section: Introductionmentioning
confidence: 99%
“…Evaluations of testing programmes conducted on university settings commonly focus on test performance [ 11 ], number of tests performed, disease transmission and infections detected, or the technical, logistical, and regulatory processes that enabled the scale-up of testing onsite [ 12 , 13 , 14 , 15 , 16 , 17 , 18 , 19 , 20 , 21 , 22 , 23 , 24 , 25 ]. Some studies include surveys which are primarily focused on student transmissibility or symptom reporting [ 23 , 26 ].…”
Section: Introductionmentioning
confidence: 99%